Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®)

The aim of this study was to evaluate the factors contributing towards erectile dysfunction (ED) in patients followed-up in the Institut Urologi & Nefrologi, Hospital Kuala Lumpur between 1st . March 1999 to 31st . August 1999. One hundred and fiftyfour patients were included in this study. The...

Full description

Saved in:

Bibliographic Details
Main Author:	Nasuha , Noor Azam
Format:	Thesis
Language:	English
Published:	2001
Subjects:	RD Surgery
Online Access:	http://eprints.usm.my/37486/1/dr_noor_azam_bin_nasura%28MRM%29-RD_SURGERY.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.37486
record_format	uketd_dc
spelling	my-usm-ep.374862019-04-12T05:27:05Z Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®) 2001 Nasuha , Noor Azam RD Surgery The aim of this study was to evaluate the factors contributing towards erectile dysfunction (ED) in patients followed-up in the Institut Urologi & Nefrologi, Hospital Kuala Lumpur between 1st . March 1999 to 31st . August 1999. One hundred and fiftyfour patients were included in this study. The mean age of the patients was 52.68 years. The youngest was 22 and the oldest was 76 year-old. Most were between the age of 45 and 65 year-old. Diabetes mellitus and hypertension played a major role as contributing factors in the overall study population. 45.4% of the patients have diabetes mellitus and 29.2% have hypertension. 41.5% of the patients have single contributing factor towards erectile dysfunction whereas 29.2% have two and 10.4% of the patients have three contributing factors. In 18.2% of the studied patients the cause of ED were unknown. In term of racial distribution, Malays contributed 48.7% of the study sample; Indian 25.3% and Chinese constitute about 22.1 %. 35 patients who fulfilled the inclusion criteria were enrolled in the clinical trial with transurethral alprostadil (MUSE®). Thirty patients (85.6%) completed the in-clinic titration phase. Of these, 18 patients (60%) responded well to the MUSE® and they were sent home with the medication. However only 33.3% of patients completed the home phase. In conclusion, diabetes mellitus plays an important role in our patients with erectile dysfunction and MUSE® is one of the alternative treatment for such condition. 2001 Thesis http://eprints.usm.my/37486/ http://eprints.usm.my/37486/1/dr_noor_azam_bin_nasura%28MRM%29-RD_SURGERY.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	RD Surgery
spellingShingle	RD Surgery Nasuha , Noor Azam Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®)
description	The aim of this study was to evaluate the factors contributing towards erectile dysfunction (ED) in patients followed-up in the Institut Urologi & Nefrologi, Hospital Kuala Lumpur between 1st . March 1999 to 31st . August 1999. One hundred and fiftyfour patients were included in this study. The mean age of the patients was 52.68 years. The youngest was 22 and the oldest was 76 year-old. Most were between the age of 45 and 65 year-old. Diabetes mellitus and hypertension played a major role as contributing factors in the overall study population. 45.4% of the patients have diabetes mellitus and 29.2% have hypertension. 41.5% of the patients have single contributing factor towards erectile dysfunction whereas 29.2% have two and 10.4% of the patients have three contributing factors. In 18.2% of the studied patients the cause of ED were unknown. In term of racial distribution, Malays contributed 48.7% of the study sample; Indian 25.3% and Chinese constitute about 22.1 %. 35 patients who fulfilled the inclusion criteria were enrolled in the clinical trial with transurethral alprostadil (MUSE®). Thirty patients (85.6%) completed the in-clinic titration phase. Of these, 18 patients (60%) responded well to the MUSE® and they were sent home with the medication. However only 33.3% of patients completed the home phase. In conclusion, diabetes mellitus plays an important role in our patients with erectile dysfunction and MUSE® is one of the alternative treatment for such condition.
format	Thesis
qualification_level	Master's degree
author	Nasuha , Noor Azam
author_facet	Nasuha , Noor Azam
author_sort	Nasuha , Noor Azam
title	Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®)
title_short	Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®)
title_full	Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®)
title_fullStr	Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®)
title_full_unstemmed	Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®)
title_sort	erectile dysfunction patients in institut urologi & nefrologi (iun), hospital kuala lumpur (hkl) and clinical trial with transuretheral alprostadil (muse®)
granting_institution	Universiti Sains Malaysia
granting_department	Pusat Pengajian Sains Perubatan
publishDate	2001
url	http://eprints.usm.my/37486/1/dr_noor_azam_bin_nasura%28MRM%29-RD_SURGERY.pdf
_version_	1747820665107382272

Erectile Dysfunction Patients In Institut Urologi & Nefrologi (Iun), Hospital Kuala Lumpur (Hkl) And Clinical Trial With Transuretheral Alprostadil (Muse®)

Similar Items